Evidence map›Paper›PMID 40736816›Full record

ReviewAdvances in experimental medicine and biology2025

Blue Cone Monochromatism.

Kristina J Hartung, Stephen H Tsang, Tarun Sharma, Vlad Diaconita

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kristina J HartungDepartment of Ophthalmology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Stephen H TsangDepartment of Ophthalmology, Columbia University, New York, NY, USA. sht2@cumc.columbia.edu.
Tarun SharmaDepartment of Ophthalmology, Columbia University, New York, NY, USA.
Vlad DiaconitaDepartment of Ophthalmology, Columbia University, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blue cone monochromatism (BCM) is a rare X-linked recessive disease characterized by an absent function of L and M cones and a normal function of S cones and rods. The estimated prevalence is 1 in 100,000 individuals, and males are predominantly affected. The patients usually present at birth or in early infancy. The clinical features include impaired color vision (patients only see colors in the blue range of light) and poor visual acuity (between 20/80 and 20/200), photophobia, pendular nystagmus (which may improve over time), and myopia. The condition is typically stationary, but progressive central retinal atrophy may be seen later in life. The presentation is similar to rod monochromatism (achromatopsia), an autosomal recessive disease that affects all three types of cones. However, BCM patients have better visual acuity, preserved tritan discrimination, and myopia (as opposed to hyperopia in achromatopsia). Electrophysiology, psychophysical testing (using Berson plates), and family history (x-linked recessive vs. autosomal recessive) help distinguish the two conditions.

Indexed as

Color Vision DefectsGenetic Diseases, X-LinkedRetinal Cone Photoreceptor CellsHumansMaleVisual AcuityBlue cone monochromatismColor blindnessS-cone monochromatismX-linked

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.